Advertisement
Advertisement

CBIO

CBIO logo

Crescent Biopharma, Inc. Common Stock

19.61
USD
Sponsored
+1.15
+6.23%
May 13, 15:59 UTC -4
Closed
exchange

Pre-Market

20.18

+0.57
+2.93%

Crescent Biopharma, Inc. Common Stock Profile

About

Crescent Biopharma is a biotechnology company dedicated to advancing novel precision engineered molecules targeting validated biology to advance care for patients with solid tumors. Crescent Biopharma, formerly known as GlycoMimetics Inc., is based in ROCKVILLE, Md.

Info & Links

CEO

Joshua Brumm

Headquarters

300 FIFTH AVENUE
WALTHAM, MA 02451, UNITED STATES

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

www.crescentbiopharma.com

Auditor

PricewaterhouseCoopers LLP

Share holders

66

Employees

44

Crescent Biopharma, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization2

556.57M

Enterprise Value

343.38M

Enterprise Value/EBITDA(ttm)

-2.10

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

1.33

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-125.38%

Return on Invested Capital(ttm)

-158.00%

Return on Assets(ttm)

-104.16%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-163.39M

Net Income Available to Common(ttm)

-153.94M

Diluted EPS(ttm)

-14.21

Share Statistics

Beta (5Y Monthly)

1.04

52-Week Change

--

S&P 500 52-Week Change

26.33%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

27.56M

Dividend Yield

0.00%

Float4

13.34M

% Held by Insiders

4.00%

% Held by Institutions

75.19%

Balance Sheet

Total Cash(mrq)

213.19M

Total Cash Per Share(mrq)

7.74

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

6.56%

Quick Ratio(mrq)

6.56%

Book Value Per Share(mrq)

7.37

Cash Flow

Operating Cash Flow Per Share(ytd)

-6.87

Free Cash Flow(ytd)

-72.45M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement